ClinConnect ClinConnect Logo
Search / Trial NCT05527405

Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes

Launched by MAPHABIT, INC. · Sep 1, 2022

Trial Information

Current as of October 25, 2025

Not yet recruiting

Keywords

Alzheimer Disease Dementia Caregiver Burden Activities Of Daily Living Assistive Technology

ClinConnect Summary

This clinical trial is studying a new training program designed to help caregivers of individuals with Alzheimer's disease or related dementias. The program uses a system called MapHabit, which provides visual tools to help improve the daily care and independence of patients. The trial will involve 50 pairs of patients and their primary caregivers, who will be split into two groups: one group will use the MapHabit system alone, while the other group will use it along with the caregiver training program. The goal is to see if adding this training helps reduce the stress and challenges caregivers face while caring for their loved ones.

To be eligible for this trial, participants must have a diagnosis of mild to moderate Alzheimer's disease or related dementia, and their caregiver should be the main person providing daily support. Both the patient and caregiver need to be proficient in English. If you join the study, you can expect to participate for six months and receive support through the MapHabit system, which aims to enhance both your experience and the quality of care provided. This study is not yet recruiting participants, but it represents an important step in improving the lives of caregivers and those they care for.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
  • Participating caregiver of individual with dementia must be the primary caregiver
  • Proficient in English
  • Exclusion Criteria:
  • Individual not diagnosed with ADRD
  • Participating caregiver of individual with dementia is NOT the primary caregiver
  • Not proficient in English

About Maphabit, Inc.

Maphabit, Inc. is a clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Specializing in the design and management of clinical studies, Maphabit focuses on delivering effective solutions in the realms of pharmaceuticals and medical devices. With a commitment to adhering to the highest ethical standards and regulatory guidelines, the company collaborates with healthcare professionals and research institutions to ensure the integrity and reliability of its clinical trials. Maphabit strives to enhance patient outcomes and contribute to the evolving landscape of medical science through rigorous data analysis and a patient-centered approach.

Locations

Atlanta, Georgia, United States

Patients applied

0 patients applied

Trial Officials

Stuart Zola

Principal Investigator

MapHabit, Inc.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials